| Symbol | AIMLF |
|---|---|
| Name | AI / ML INNOVATIONS INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | V8W 1G2 Canada BC 645 Fort Street Suite 203 |
| Telephone | +1 778-405-0882 |
| Fax | — |
| — | |
| Website | https://www.aiml.health/ |
| Incorporation | CA |
| Incorporated On | 1983 |
| Employees | — |
| Fiscal Year | 4/30 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Baker Tilly WM LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Canadian Securities Exchange |
| CIK | 0000819962 |
| Description | AI/ML Innovations Inc. (AIML) is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. Our proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights - supporting earlier diagnosis, personalized treatment, and more effective care. With a growing portfolio of regulatory filings, including a 510(k) premarket notification and a registered FDA Device Master File, AIML is committed to rigorous validation and broad interoperability. Additional info from OTC: |
No news found.